Difficulties Abound

As part of its Evidence Gap series, the New York Times has a backgrounder on the obstacles facing personalized medicine -- getting pharmaceutical companies to develop tests, insurance companies to cover the cost, and doctors to order the test. It also goes into the confusion of contradictory validation study results as well as from inconclusive test results, saying it is not always clear what should be done medically.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.